General Information of Drug (ID: DMSG08M)

Drug Name
BP-C1
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 1 [1]
Cross-matching ID
TTD ID
D05NHT

References

1 ClinicalTrials.gov (NCT01861509) BP-C1 in Metastatic Breast Cancer Patients. U.S. National Institutes of Health.